Prospective Evaluation of Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma.

about

Systematic review of site distribution of bone metastases in differentiated thyroid cancer.Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma."Turn-Off" Fluorescent Sensor for Pamidronate Disodium and Zoledronic Acid Based on Newly Synthesized Carbon Dots from Black Tea.

P2860

Q39083212-169F9EF2-5DAB-44D6-B9BD-25D3B825AC94 Q39357548-067F93E4-C31D-4CB0-A032-27746C6A65E1 Q55318655-8D3A60D6-E1EB-4FE7-B571-92FC1E488E12

P2860

Prospective Evaluation of Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma.

Item

http://www.wikidata.org/entity/Q41241592

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Prospective Evaluation of Zole ...... ferentiated Thyroid Carcinoma.

@en

type

Item

label

Prospective Evaluation of Zole ...... ferentiated Thyroid Carcinoma.

@en

prefLabel

Prospective Evaluation of Zole ...... ferentiated Thyroid Carcinoma.

@en

P1476

Prospective Evaluation of Zole ...... ferentiated Thyroid Carcinoma.

@en

P2093

Iwao Sugitani

http://www.w3.org/2001/XMLSchema#string

Jun Manabe

http://www.w3.org/2001/XMLSchema#string

Kazuhisa Toda

http://www.w3.org/2001/XMLSchema#string

Satoshi Miyata

http://www.w3.org/2001/XMLSchema#string

Soshi Takao

http://www.w3.org/2001/XMLSchema#string

Yorihisa Orita

http://www.w3.org/2001/XMLSchema#string

P2860

Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates

Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer.

Novel therapeutic approaches to cancer patients with bone metastasis.

Single-stage posterior decompression and stabilization for metastasis of the thoracic spine: prognostic factors for functional outcome and patients' survival.

Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people.

Patients with bone metastases from solid tumors initiating treatment with a bone-targeted agent in 2011: a descriptive analysis using oncology clinic data in the US.

Clinical usefulness of bone markers in prostate cancer with bone metastasis.

Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancer.

Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status.

P2888

s10434-015-4497-0

P304

4008-4013

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-015-4497-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1005733477

http://www.w3.org/2001/XMLSchema#string

P698

25762482

http://www.w3.org/2001/XMLSchema#string

Prospective Evaluation of Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma.

about

P2860

P2860

Prospective Evaluation of Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698